| Glycolytic metabolism and tumour response to fractionated irradiation UGA Sattler, SS Meyer, V Quennet, C Hoerner, H Knoerzer, C Fabian, ... Radiotherapy and oncology 94 (1), 102-109, 2010 | 250 | 2010 |
| Tumor lactate content predicts for response to fractionated irradiation of human squamous cell carcinomas in nude mice V Quennet, A Yaromina, D Zips, A Rosner, S Walenta, M Baumann, ... Radiotherapy and Oncology 81 (2), 130-135, 2006 | 227 | 2006 |
| Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation A Yaromina, M Krause, H Thames, A Rosner, M Krause, F Hessel, ... Radiotherapy and oncology 83 (3), 304-310, 2007 | 174 | 2007 |
| Prognostic significance of carbonic anhydrase IX expression in cancer patients: a meta-analysis SJA van Kuijk, A Yaromina, R Houben, R Niemans, P Lambin, LJ Dubois Frontiers in oncology 6, 69, 2016 | 151 | 2016 |
| Decision support systems for personalized and participative radiation oncology P Lambin, J Zindler, BGL Vanneste, L Van De Voorde, D Eekers, ... Advanced drug delivery reviews 109, 131-153, 2017 | 150 | 2017 |
| Is there a causal relationship between genetic changes and radiomics-based image features? An in vivo preclinical experiment with doxycycline inducible GADD34 tumor cells KM Panth, RTH Leijenaar, S Carvalho, NG Lieuwes, A Yaromina, ... Radiotherapy and Oncology 116 (3), 462-466, 2015 | 138 | 2015 |
| Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: the need for a multivariate approach in … A Yaromina, D Zips, HD Thames, W Eicheler, M Krause, A Rosner, ... Radiotherapy and oncology 81 (2), 122-129, 2006 | 126 | 2006 |
| TH-302 in Combination with Radiotherapy Enhances the Therapeutic Outcome and Is Associated with Pretreatment [18F]HX4 Hypoxia PET Imaging SGJA Peeters, CML Zegers, R Biemans, NG Lieuwes, ... Clinical cancer research 21 (13), 2984-2992, 2015 | 120 | 2015 |
| Cancer stem cells: targets and potential biomarkers for radiotherapy M Krause, A Yaromina, W Eicheler, U Koch, M Baumann Clinical cancer research 17 (23), 7224-7229, 2011 | 116 | 2011 |
| Combining radiotherapy with immunotherapy: the past, the present and the future EJ Van Limbergen, DK De Ruysscher, V Olivo Pimentel, D Marcus, ... The British Journal of Radiology 90 (1076), 20170157, 2017 | 113 | 2017 |
| Radiobiological hypoxia, histological parameters of tumour microenvironment and local tumour control after fractionated irradiation A Yaromina, H Thames, X Zhou, S Hering, W Eicheler, A Dörfler, ... Radiotherapy and Oncology 96 (1), 116-122, 2010 | 106 | 2010 |
| Decreased repopulation as well as increased reoxygenation contribute to the improvement in local control after targeting of the EGFR by C225 during fractionated irradiation M Krause, G Ostermann, C Petersen, A Yaromina, F Hessel, A Harstrick, ... Radiotherapy and oncology 76 (2), 162-167, 2005 | 105 | 2005 |
| Radiotherapy combined with the immunocytokine L19-IL2 provides long-lasting antitumor effects CML Zegers, NH Rekers, DHF Quaden, NG Lieuwes, A Yaromina, ... Clinical cancer research 21 (5), 1151-1160, 2015 | 103 | 2015 |
| Individualization of cancer treatment from radiotherapy perspective A Yaromina, M Krause, M Baumann Molecular oncology 6 (2), 211-221, 2012 | 103 | 2012 |
| Hypoxia-activated prodrugs and (lack of) clinical progress: The need for hypoxia-based biomarker patient selection in phase III clinical trials L Spiegelberg, R Houben, R Niemans, D de Ruysscher, A Yaromina, ... Clinical and translational radiation oncology 15, 62-69, 2019 | 101 | 2019 |
| Prediction of clonogenic cell survival curves based on the number of residual DNA double strand breaks measured by γH2AX staining A Menegakis, A Yaromina, W Eicheler, AR Dörfler, B Beuthien-Baumann, ... International journal of radiation biology 85 (11), 1032-1041, 2009 | 101 | 2009 |
| Targeting carbonic anhydrase IX by nitroimidazole based sulfamides enhances the therapeutic effect of tumor irradiation: a new concept of dual targeting drugs L Dubois, SGJA Peeters, SJA Van Kuijk, A Yaromina, NG Lieuwes, ... Radiotherapy and Oncology 108 (3), 523-528, 2013 | 96 | 2013 |
| Diverse effects of combined radiotherapy and EGFR inhibition with antibodies or TK inhibitors on local tumour control and correlation with EGFR gene expression K Gurtner, Y Deuse, R Bütof, K Schaal, W Eicheler, R Oertel, R Grenman, ... Radiotherapy and Oncology 99 (3), 323-330, 2011 | 85 | 2011 |
| Exploratory study of the prognostic value of microenvironmental parameters during fractionated irradiation in human squamous cell carcinoma xenografts A Yaromina, T Kroeber, A Meinzer, S Boeke, H Thames, M Baumann, ... International Journal of Radiation Oncology* Biology* Physics 80 (4), 1205-1213, 2011 | 76 | 2011 |
| Effect of increase of radiation dose on local control relates to pre-treatment FDG uptake in FaDu tumours in nude mice C Schütze, R Bergmann, A Yaromina, F Hessel, J Kotzerke, J Steinbach, ... Radiotherapy and oncology 83 (3), 311-315, 2007 | 74 | 2007 |
